Cargando…
Loss of FOXO transcription factors in the liver mitigates stress-induced hyperglycemia
OBJECTIVE: Stress-induced hyperglycemia is associated with poor outcomes in nearly all critical illnesses. This acute elevation in glucose after injury or illness is associated with increased morbidity and mortality, including multiple organ failure. Stress-induced hyperglycemia is often attributed...
Autores principales: | Garcia Whitlock, Anna E., Sostre-Colón, Jamarie, Gavin, Matthew, Martin, Niels D., Baur, Joseph A., Sims, Carrie A., Titchenell, Paul M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175408/ https://www.ncbi.nlm.nih.gov/pubmed/33964506 http://dx.doi.org/10.1016/j.molmet.2021.101246 |
Ejemplares similares
-
AKT controls protein synthesis and oxidative metabolism via combined mTORC1 and FOXO1 signalling to govern muscle physiology
por: Jaiswal, Natasha, et al.
Publicado: (2021) -
Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms
por: Sostre-Colón, Jaimarie, et al.
Publicado: (2021) -
Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis
por: Uehara, Kahealani, et al.
Publicado: (2022) -
Liver Fat – Gone, but Not Forgotten?
por: Titchenell, Paul M., et al.
Publicado: (2023) -
MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver
por: Tian, Fang, et al.
Publicado: (2020)